» Authors » Andreas Greinacher

Andreas Greinacher

Explore the profile of Andreas Greinacher including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 401
Citations 9501
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Moller C, Terholsen H, Schmoker O, Le T, Wesche J, Schmiade P, et al.
Chembiochem . 2025 Feb; :e202500072. PMID: 40013737
The supply of blood products such as red blood cells poses a challenge due to rising demand and declining donor numbers. Careful matching of blood products of different types is...
2.
Last J, Birschmann I, Lindau S, Konstantinides S, Grottke O, Nowak-Gottl U, et al.
Pharmaceuticals (Basel) . 2025 Feb; 18(2). PMID: 40005984
Major bleeding or emergency surgery are the most frequently observed emergency situations in patients anticoagulated with vitamin K antagonists (VKAs) or direct oral anticoagulants (DOACs). The restart of anticoagulation after...
3.
Hausler S, Schonborn L, Gradl J, Cadamuro J, Steinbrucker K, Broto M, et al.
N Engl J Med . 2025 Feb; 392(7):719-721. PMID: 39938100
No abstract available.
4.
Wang J, Warkentin T, Schonborn L, Wheeler M, Geerts W, Costedoat-Chalumeau N, et al.
N Engl J Med . 2025 Feb; 392(10):995-1005. PMID: 39938091
Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is associated with antibodies that target platelet factor 4 (PF4) and are heparin-independent. VITT antibodies are implicated in acute, transient prothrombotic disorders that are...
5.
Muller L, Dabbiru V, Rutten L, Bos R, Zahn R, Handtke S, et al.
Vaccines (Basel) . 2025 Jan; 13(1. PMID: 39852782
Background/objectives: Adenoviral vector-based vaccines against COVID-19 rarely cause vaccine-induced immune thrombocytopenia and thrombosis (VITT), a severe adverse reaction caused by IgG antibodies against platelet factor 4 (PF4). To study VITT,...
6.
Loroch S, Panagiotidis E, Klewe K, Swieringa F, Heemskerk J, Heemskerk J, et al.
Thromb Haemost . 2025 Jan; PMID: 39814053
Comprehensive characterization of platelets requires various functional assays and analytical techniques, including omics disciplines, each demanding a separate aliquot of the given sample. Consequently, sample material for each assay is...
7.
Wang X, Aurich K, Zhang W, Ehrhardt A, Greinacher A, Bayer W
Viruses . 2024 Nov; 16(11). PMID: 39599861
Adenoviruses are important human pathogens that are widespread and mainly associated with respiratory and gastrointestinal infections. In a previous study on human adenovirus (HAdV) seroprevalence, we observed reduced binding antibody...
8.
Nilius H, Naas S, Studt J, Tsakiris D, Greinacher A, Mendez A, et al.
J Thromb Haemost . 2024 Nov; 23(2):684-691. PMID: 39536820
Background: Following the current guidelines, immunoassays for the diagnosis of heparin-induced thrombocytopenia (HIT) are interpreted dichotomously, with test results categorized as either positive or negative. However, the extent to which...
9.
Zaninetti C, Greinacher A
Br J Haematol . 2024 Sep; 205(6):2139-2141. PMID: 39329208
Thrombocytopenia 4 (THC4) is an extremely rare form of inherited thrombocytopenia caused by mutations in the gene encoding cytochrome c (CYCS). The mechanism leading to reduced blood platelets remains unclear,...
10.
Vollherbst J, Zaninetti C, Greinacher A, Durken M
Thromb Haemost . 2024 Sep; PMID: 39299272
No abstract available.